Clear Protocol is a pioneering AI-powered Software-as-a-Service startup founded in 2015, with a mission to enhance clinical validation at the point of care using innovative, unobtrusive AI-driven solutions. The company addresses the critical need for contemporaneous validation of clinical practices in healthcare settings, which has been historically hindered by the impracticality of traditional validation devices.
Traditional devices like desktop computers, iPads, or smartphones present risks such as hand contamination, inconvenience of access, and distractions, making real-time validation at the point of care a significant challenge. Clear Protocol, however, offers a practical, unobtrusive system that enables real-time validation at the point of care, without disrupting the clinician's workflow, ultimately ensuring safe clinical practices at all times.
With a focus on the Information Technology sector, Clear Protocol recently secured a $50.00K Pre Seed Round investment on 19 September 2022, demonstrating the confidence of investors in the company's innovative approach to addressing crucial needs in the healthcare industry.